UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
Status:
Terminated
Trial end date:
2019-02-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to improve the clinical outcomes of research subjects with
high-risk multiple myeloma in the context of the immediately preceding Total therapy 5 trial
2008-02 and Total therapy 3 trials 2003-33 and 2006-66.